Compulsive use of dopamine replacement therapy in parkinson's disease: Insights into the neurobiology of addiction

Addiction

Volumn 107, Issue 2, 2012, Pages 250-251

  Brown, Robyn M ^a   Lawrence, Andrew J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Addiction; Dopamine; Parkinson's disease.

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ADDICTION; ARTICLE; HUMAN; PARKINSON DISEASE; PSYCHOLOGICAL ASPECT; SYNDROME;

ANTIPARKINSON AGENTS; DOPAMINE AGENTS; HUMANS; PARKINSON DISEASE; SUBSTANCE-RELATED DISORDERS; SYNDROME;

EID: 84855930955     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03641.x     Document Type: Note

References (9)

1. Ambermoon P., Carter A., Hall W., Dissanayaka N., O'Sullivan J. Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction? Addiction 2012; 107: 241-7.
2. American Psychiatric Association. DSM-5 Development 2010. Available from: (accessed 16 August 2011; archived by Webcite at ).
3. Dagher A., Robbins T. W. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 2009; 61: 502-10.
4. Wiecki T. V., Frank M. J. Neurocomputational models of motor and cognitive deficits in Parkinson's disease. Prog Brain Res 2010; 183: 275-97.
5. Evans A. H., Lawrence A. D., Cresswell S. A., Katzenschlager R., Lees A. J. Compulsive use of dopaminergic drug therapy in Parkinson's disease: reward and anti-reward. Mov Disord 2010; 25: 867-76.
6. Evans A. H., Lawrence A. D., Potts J., Appel S., Lees A. J. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 2005; 65: 1570-74.
7. 11C raclopride PET study. Brain 2009; 132: 1376-85.
8. Evans A. H., Pavese N., Lawrence A. D., Tai Y. F., Appel S., Doder M. etal. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006; 59: 852-8.
9. O'Sullivan S. S., Wu K., Politis M., Lawrence A. D., Evans A. H., Bose S. K. etal. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 2011; 134: 969-78.